Impact of initial antibiotic choice and delayed appropriate treatment on the outcome of Staphylococcus aureus bacteremia

European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology
R KhatibL B Johnson

Abstract

The study presented here investigated the impact of initial antibiotic choice (beta-lactams vs vancomycin) on the outcome of 342 patients with Staphylococcus aureus bacteremia (50.9% with methicillin-resistant isolates) encountered between 1 January 2002 and 30 June 2003. Initial antibiotics were inappropriate (beta-lactams) in 60 (34.5%) methicillin-resistant cases and suboptimal (vancomycin) in 62 (36.9%) methicillin-susceptible cases. Time to effective antibiotic therapy was longer in methicillin-resistant cases (25.5+/-28.6 vs 9.6+/-16.6 h; p<0.0005). All-cause in-hospital mortality was higher with inappropriate therapy (35.0 vs 20.9%; p=0.02). Initial vancomycin treatment was associated with a higher incidence of delayed clearance (>or=3 days) of methicillin-susceptible bacteremia (56.3 vs 37.0%; p=0.03). The results indicate inappropriate initial therapy is associated with higher in-hospital mortality and initial vancomycin may delay clearance.

References

Dec 10, 1998·Journal of Internal Medicine·L LeiboviciS D Pitlik
Apr 19, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J S LiG R Corey
Dec 20, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E CosgroveYehuda Carmeli
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas P LodiseMichael J Rybak
Sep 5, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sung-Han KimKang-Won Choe
Jan 1, 2004·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Olivier LesensDaniel Christmann
Jan 16, 2004·Scandinavian Journal of Infectious Diseases·Leonard B JohnsonRiad Khatib
Feb 17, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Vance G FowlerSharon J Peacock

❮ Previous
Next ❯

Citations

Dec 24, 2008·Analytical and Bioanalytical Chemistry·Albrecht Pfäfflin, Erwin Schleicher
Dec 11, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C J BeestonR J Young
Feb 3, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·B A Cunha, F M Pherez
Sep 5, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Z A KanafaniH W Boucher
Oct 5, 2013·The Spine Journal : Official Journal of the North American Spine Society·Yoshiharu KawaguchiTomoatsu Kimura
Sep 16, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Marin H KollefScott T Micek
Apr 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ravina KullarMichael J Rybak
Aug 26, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David R CameronAnton Y Peleg
Aug 30, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kevin W McConeghyKeith A Rodvold
Oct 16, 2010·The Journal of Antimicrobial Chemotherapy·Mical PaulLeonard Leibovici
Nov 30, 2012·The Journal of Antimicrobial Chemotherapy·Pascal M DohmenRicardo L Chaves
Jul 2, 2010·Current Opinion in Infectious Diseases·Winfried V Kern
Aug 25, 2010·Antimicrobial Agents and Chemotherapy·Mical PaulLeonard Leibovici
Feb 27, 2010·Clinical Chemistry and Laboratory Medicine : CCLM·Bárbara L dos Anjos, Helena Z W Grotto
Apr 20, 2014·The Journal of Antimicrobial Chemotherapy·Hong FooSebastiaan J van Hal
Apr 2, 2011·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·K LucianiD Estripeaut
Dec 15, 2010·Critical Care Clinics·Duane J Funk, Anand Kumar
Aug 12, 2009·Infectious Disease Clinics of North America·Matthew R MorrellMarin H Kollef
Feb 12, 2011·Internal Medicine Journal·S HewagamaL J Einsiedel
Jul 15, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A LaluezaJ M Aguado
Apr 9, 2015·Disease Markers·Christian LeliAntonella Mencacci
Jun 3, 2015·Current Infectious Disease Reports·Stephen Y Liang, Anand Kumar
Nov 15, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J O RobinsonR J Murray
Dec 16, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J Segreti
Apr 14, 2010·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·V CattoirP Lesprit
Apr 9, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·B I Eisenstein
Apr 9, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·C K Naber

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

© 2021 Meta ULC. All rights reserved